Biotechnology and Its Simultaneous Evolution by Leonardo Brantes Bacellar Mendes in Cohesive Journal of Microbiology & Infectious Disease
Biotechnology is currently developing across borders rapidly and simultaneously. New equipment is continuously developed and refined to improve production processes and quality control associated with obtaining the most diverse bioproducts such as biosurfactants, natural dyes, antioxidants and antibiotics. There is no industrial biotechnological process that works generically and each requires particular solutions that can sustain a good scale up from scientific and technological points of view.
State-of-the-art centrifuges and decanters "taylor made" with high commercial value have a prominent place in unit operations for the separation of micro-organisms of interest or the culture medium containing bioproducts or only for clarification of the final product as in the industrial procurement of wine.
High-sensitivity flow cytometers with cellular recognition capability utilizing information on biochemical composition, shape and size help in screening and sorting out new strains of microorganisms to be grown for the discovery of promising new molecules (e.g. antivirals to fight HIV).
On the other hand, the huge variety of new newly synthesized reagents – molecular probes – has been assisting in the detection and quantification of target molecules "in situ", an extremely important fact for rapid evaluation and intervention throughout bioprocesses with short production cycles.
The company Life Technologies Corporation (Figure 1), recently acquired by Thermo Fisher Scientific, has available in its catalog of molecular probes 35 reference standards for flow cytometry at the disposal of the international scientific community, in addition to other catalogs containing hundreds of other equipment, kits and reagents.
For more articles in Infectious Disease Open Access Journals, Please click on link: https://crimsonpublishers.com/cjmi/